VCs Back DVS Sciences With $14.6M
A group of investors including 5AM Ventures, Pfizer Venture Investments, Mohr Davidow, the Roche Venture Fund and the Ontario Institute for Cancer Research have put $14.6 million into DVS Sciences Inc. With offices in Ontario and Sunnyvale, Calif., DVS Sciences is a manufacturer of highly multi-parameter single-cell analyzers and reagents for biological research and clinical applications. The company will use the Series A financing to expand its commercial manufacturing efforts.
14 July 2011•3 mins read
